AbbVie Reports Third-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
AbbVie (ABBV) Tops Q3 EPS by 10c, Offers Guidance
October 29, 2021 7:42 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $3.33, $0.10 better than the analyst estimate of $3.23. Revenue for the quarter came in at $14.34 billion versus the consensus estimate of $14.35 billion.
GUIDANCE:
AbbVie sees FY2021 EPS of $12.63-$12.67, versus the consensus of... More
